Polansky J, Friedman Z, Fauss D, Kurtz R, Alvarado J
Department of Ophthalmology, University of California Medical Center, San Francisco.
Int Ophthalmol. 1989 Jan;13(1-2):95-7. doi: 10.1007/BF02028646.
The effects of timolol and betaxolol were compared for blocking beta agonist stimulation of cyclic-AMP in cultured human trabecular meshwork cells. Epinephrine (10(-5) M) produced a large and rapid increase in HTM cyclic-AMP; timolol (10(-6) M), at concentrations readily achieved in the aqueous humor after 0.5% eyedrops, completely blocked this effect. Recovery from timolol treatment appeared to be relatively slow, with only a 30-40% recovery observed by 9 hours. In comparison, betaxolol (10(-6) M) produced a smaller blockade of the epinephrine effects; a rapid recovery from the betaxolol effects was observed, with a greater than half-maximal response to epinephrine observed 15 minutes after removal of this beta blocker. These findings may help to explain the clinical observations of an outflow facility effect of epinephrine when used in combination protocols with betaxolol, but not with timolol.
比较了噻吗洛尔和倍他洛尔对培养的人小梁网细胞中环磷酸腺苷(cAMP)的β激动剂刺激的阻断作用。肾上腺素(10⁻⁵M)使小梁网细胞中的cAMP迅速大幅增加;噻吗洛尔(10⁻⁶M)在0.5%滴眼液滴眼后房水中易于达到的浓度下,完全阻断了这种作用。噻吗洛尔治疗后的恢复似乎相对较慢,9小时时仅观察到30%-40%的恢复。相比之下,倍他洛尔(10⁻⁶M)对肾上腺素作用的阻断较小;观察到倍他洛尔作用的快速恢复,在去除这种β受体阻滞剂15分钟后,对肾上腺素的反应大于半数最大反应。这些发现可能有助于解释在与倍他洛尔而非噻吗洛尔联合用药方案中使用肾上腺素时,关于房水流出功能效应的临床观察结果。